Pangraf 0.25MG Capsule is a medication that contains Tacrolimus as its active ingredient, specifically formulated to aid in the prevention of organ rejection in patients who have undergone organ transplants, such as kidney, liver, or heart transplants. This immunosuppressant works by inhibiting the activation of T-lymphocytes, which are crucial components of the immune system that can attack transplanted organs. Each capsule contains 0.25mg of Tacrolimus, and it is typically prescribed as part of a comprehensive immunosuppressive regimen that may include other medications to enhance its effectiveness. Pangraf is essential for patients who require long-term immunosuppression to maintain the viability of their transplanted organs, thereby improving their quality of life and overall health outcomes.